Logo

Spotfire and Daylight CIS to Link Technologies

Oct 08, 2003

NEW YORK, Oct. 8 (GenomeWeb News) -- Spotfire and Daylight CIS, a cheminformatics firm based in Mission Viejo, Calif., today announced a technology collaboration.

The two companies said they will integrate Somerville, Mass.-based Spotfire’s Advantage Solutions analytic applications with Daylight’s chemical information systems, including Daylight Toolkits and DayCart, Daylight’s chemistry cartridge for Oracle.

Financial details of the agreement were not disclosed.

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.